Linxiang Zhao Selected Research

11-keto-boswellic acid

10/2018	Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
1/2017	Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linxiang Zhao Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 02/2005
9	Leukemia 01/2021 - 08/2007
4	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 04/2016
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 03/2015
2	Carcinogenesis 03/2022 - 03/2019
1	Alzheimer Disease (Alzheimer's Disease) 03/2022
1	Inflammation (Inflammations) 03/2022
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Lymphoma (Lymphomas) 08/2009

Drug/Important Bio-Agent (IBA)

4	Apoptosis Regulatory ProteinsIBA 03/2022 - 03/2015
3	PiperazineIBA 02/2020 - 01/2016
3	Biological ProductsIBA 01/2019 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 02/2016 - 02/2005
3	artenimol (dihydroartemisinin)IBA 01/2016 - 08/2009
2	Histones (Histone)IBA 01/2021 - 02/2016
2	methyl 2- cyano- 3,11- dioxo- 18beta- olean- 1,12- dien- 30- oateIBA 10/2020 - 02/2020
2	Cytotoxins (Cytolysins)IBA 02/2020 - 02/2016
2	Histone Deacetylase InhibitorsIBA 01/2019 - 02/2016
2	11-keto-boswellic acidIBA 10/2018 - 01/2017
2	AcidsIBA 10/2017 - 08/2007
2	Sulfhydryl Compounds (Thiols)IBA 02/2016 - 02/2005
2	Glycyrrhetinic Acid (Po 12)IBA 06/2010 - 01/2010
2	EstersIBA 01/2010 - 08/2009
2	Glutathione (Reduced Glutathione)IBA 01/2010 - 02/2005
2	18alpha-glycyrrhetinic acidIBA 01/2010 - 08/2007
1	venetoclaxIBA 04/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2022
1	Checkpoint Kinase 1IBA 04/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2022
1	PyrimidinesIBA 01/2021
1	NIMA-Interacting Peptidylprolyl IsomeraseIBA 03/2019
1	proto-oncogene proteins pimIBA 01/2019
1	indoleIBA 01/2019
1	usnic acidIBA 01/2019
1	flavanoneIBA 01/2019
1	Cyclin D1IBA 10/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017
1	Pharmaceutical PreparationsIBA 12/2017
1	PropionatesIBA 10/2017
1	quinolineIBA 04/2016
1	QuinolinesIBA 04/2016
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 04/2016
1	ProdrugsIBA 02/2016
1	DisulfidesIBA 02/2016
1	EthersIBA 01/2016
1	psammaplin AIBA 01/2016
1	IronIBA 03/2015
1	NitrogenIBA 06/2010
1	methyl 2- cyano- 3,11- dioxooleana- 1,12- dien- 30- oateIBA 01/2010
1	Chalcone (Benzalacetophenone)IBA 08/2009
1	Ether (Diethyl Ether)IBA 08/2009
1	ethacrynic acid butyl esterIBA 08/2007
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2007
1	Glutathione Transferase (Glutathione S-Transferase)IBA 08/2007
1	DiureticsIBA 08/2007
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 08/2007

Therapy/Procedure

4	Therapeutics 04/2022 - 01/2016
1	Drug Therapy (Chemotherapy) 01/2022